Market Research Logo

Global Insulin Delivery Systems Market 2016-2020

Global Insulin Delivery Systems Market 2016-2020

About Insulin

The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients.

Technavio’s analysts forecast the global insulin delivery systems market to grow at a CAGR of 5.11% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global insulin delivery systems market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of insulin delivery systems.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Insulin Delivery Systems Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Novo Nordisk
  • Sanofi
  • BD
  • Eli Lilly
  • Medtronic
Other prominent vendors
  • Animas
  • Beta Bionics
  • Cellnovo
  • Copernicus
  • Dance Biopharm
  • Debiotech
  • InsuJet
  • Insulet
  • MannKind
  • Owen Mumford
  • Roche
  • SHL
  • SOOIL
  • Tandem Diabetes Care
  • Valeritas
  • West Pharma
  • Ypsomed
Market driver
  • Paradigm shift of patient pool from hospitals to specialty clinics
  • For a full, detailed list, view our report
Market challenge
  • High cost of insulin devices and competitive pricing scenario
  • For a full, detailed list, view our report
Market trend
  • Inhalers to revolutionize insulin delivery
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Insulin Delivery Systems Market 2016-2020

Technavio recognizes the following companies as the key players in the global insulin delivery systems market: Novo Nordisk, Sanofi, BD, Eli Lilly, and Medtronic.

Other Prominent Vendors in the market are: Animas, Beta Bionics, Cellnovo, Copernicus, Dance Biopharm, Debiotech, InsuJet¸ Insulet, MannKind, Owen Mumford, Roche¸ SHL, SOOIL, Tandem Diabetes Care, Valeritas, West Pharma¸ and Ypsomed.

Commenting on the report, an analyst from Technavio’s team said: “One of the key trends for market growth will be the presence of strategic alliances leading to innovative insulin delivery systems. In November 2015, Debiotech, the ARTORG Center for Biomedical Engineering Research of the University of Bern, and the Division of Endocrinology, Diabetes and Clinical Nutrition of the Bern University Hospital collaborated to develop a novel generation artificial pancreas for the personalized delivery of insulin with the accuracy of an MEMS based pump. The ambition is to create a substantial change in the treatment of diabetes and in the market for the artificial pancreas.”

According to the report, one of the key drivers for market growth will be to focus on self-management of diabetes. The adoption of insulin delivery systems for type-1 diabetes management has increased in recent years. The adoption rate is increasing due to factors such as awareness, health consciousness, and a marginal improvement of healthcare policies allowing some reimbursement for insulin delivery devices. The devices used in hospitals and specialty clinics are now being used in home care treatment by patients. This trend is seen largely because it helps save the visiting costs and fees of hospitals and clinics, and saves waiting time. In recent times, normal insulin injections are being used at home by patients with the guidance of a physician. Insulin pens, pumps, and jet injectors are handy and can be carried anywhere and can be used anytime. This flexibility has made insulin delivery device users opt for self-care diabetes management.

Further, the report states that this comes as an interesting challenge for the insulin delivery systems market, where governments are willing to encourage the usage of these devices, but with certain limitations like stringent reimbursement policies. Since these devices are expensive, and not everyone can afford it, governments have to intervene with reimbursements. For instance, reimbursement for insulin delivery devices is available in parts of the US, whereas in Australia, these devices are offered as part of the healthcare policy. Reimbursement policies are generally decided based on the healthcare budget of the country. Hence, countries like India and China, where the diabetic population is high, find it difficult to offer reimbursement for such expensive insulin delivery devices.

Companies Mentioned

Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Animas, Beta Bionics, Cellnovo, Copernicus, Dance Biopharm, Debiotech, InsuJet¸ Insulet, MannKind, Owen Mumford, Roche¸ SHL, SOOIL, Tandem Diabetes Care, Valeritas, West Pharma¸ and Ypsomed.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
      • Table Global insulin delivery systems market
      • Table Segment overview
    • Top vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
    • Market size and forecast
      • Table Global insulin delivery systems market 2015-2020 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product
    • Table Product lifecycle of insulin delivery systems
    • Table Global insulin delivery systems market by product 2015
    • Table Global insulin delivery systems market by product 2020
    • Global insulin syringes market
      • Table Global insulin syringes market: Opportunity analysis
      • Table Global insulin syringes market: Metric analysis
      • Table Global insulin syringes market 2015-2020 ($ billions)
    • Global insulin pumps market
      • Table Global insulin pumps market: Opportunity analysis
      • Table Global insulin pumps market: Metric analysis
      • Table Global insulin pumps market 2015-2020 ($ billions)
    • Global insulin pens market
      • Table Factors considered for making an ideal pen
      • Table Global insulin pens market: Opportunity analysis
      • Table Global insulin pens market: Metric analysis
      • Table Global insulin pens market 2015-2020 ($ billions)
    • Global insulin jet injectors market
      • Table Global insulin jet injectors market: Opportunity analysis
      • Table Global insulin jet injectors market: Metric analysis
      • Table Global insulin jet injectors market 2015-2020 ($ billions)
  • Market segmentation by end-user
    • Hospitals
    • Specialty diabetic clinics
    • Retail channels
  • Geographical segmentation
    • Table Global insulin delivery systems market by geography 2015
    • Table Global insulin delivery systems market by geography 2020
    • Table Global insulin delivery systems market by geography 2015-2020
    • Insulin delivery systems market in Americas
      • Table Comparative study of diabetic population (0-14 years) in specific countries in Americas 2013 and 2015
      • Table Insulin delivery systems market in Americas 2015-2020 ($ billions)
    • Insulin delivery systems market in EMEA
      • Table Comparative study of diabetic population (0-14 years) in selected European countries 2013 and 2015
      • Table Comparative study of diabetic population (0-14 years) in selected MEA countries 2013 and 2015
      • Table Insulin delivery systems market in EMEA 2015-2020 ($ billions)
    • Insulin delivery systems market in APAC
      • Table Insulin delivery systems market in APAC 2015-2020 ($ billions)
  • Market drivers
    • Increase in type-1 diabetes
      • Table Comparison of type 1 diabetes incidences 2013 and 2015
    • Paradigm shift of patient pool from hospitals to specialty clinics
    • Focus on self-management of diabetes
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • High cost of insulin devices and competitive pricing scenario
    • Threat of substitutes
    • Budget restrictions and stringent reimbursement policies
    • Complications and unmet needs
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Inhalers to revolutionize insulin delivery
    • Disruptive technologies
    • Strategic alliances leading to innovative insulin delivery systems
  • Vendor landscape
    • Competitive scenario
      • Table Global insulin delivery systems market: Competitive landscape 2015
    • Recent developments
      • Table Recent developments
      • Table Ranking of vendors 2015
  • Key vendor analysis
    • Novo Nordisk
      • Table Novo Nordisk: Metric analysis
    • Sanofi
      • Table Sanofi: Metric analysis
    • BD
      • Table BD: Metric analysis
    • Eli Lilly
      • Table Eli Lilly: Metric analysis
    • Medtronic
      • Table Medtronic: Metric analysis
    • Other prominent vendors
      • Table Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report